included, and of these only 1 is on the NEM. If amoxicillin-clavulanic acid for injection is listed in the NEM, why is there no provision for step-down care with an oral liquid dosage form? What is provided for in primary health care (ambulatory) facilities? Some of the other selections also look questionable, such as ranitidine (largely supplanted by the proton pump inhibitors, of which omeprazole was included), ibuprofen tablets (since the suspension as listed), aminophylline (deleted from the WHO Model EML a number of years ago, and especially as salbutamol inhaler was listed). Propylthiouracil is an unusual choice for a survey that is comparing retail pharmacy and hospital access, and which would be expected to concentrate on common ambulatory care conditions. However, at this stage, the list cannot be altered, so the concerns raised will need to be dealt with in the Limitations. 8. In Table 2 , the dosage form for salbutamol is stated as "dose" -is this the metered dose inhaler (200 dose)? 9. In Table 6 , it is striking that the costs were calculated using predominantly (except for the calamine lotion and salbutamol inhaler) on the costs of oral solid dosage forms, which in most cases would provide difficult to administer to a 5-year-old child. Is it the case that appropriate oral liquid dosage forms are rarely available in China and that prescriptions are filled with oral solid dosage forms which will need to be divided or somehow manipulated? Is there no access to paracetamol in liquid form, for example? This would be one of the most commonly stocked paediatric medicines in most settings. This issue deserves comment in the Discussion and Limitations. 10. Discussion -the question of the viability of the current pricing and reimbursement model applied in the province needs more description and discussion. How is the "bidding and distribution" system in the public sector applied? How might that have affected access? How are retail pharmacists remunerated, apart from the percentage mark-up on the procurement price? Are there any additional dispensing or professional fees, and how are these regulated? Are wholesale or factory-gate prices regulated or do they vary considerably. 11. Finally, a carefully English language editing is needed.
REVIEWER
Prof Hans V Hogerzeil University of Groningen, Dept of Health Sciences Global Health, University Medical Center, Groningen, Netherlands REVIEW RETURNED 30-May-2018
GENERAL COMMENTS
I have enjoyed reading the paper, which is well-written. The study is well-planned and executed, and adds interesting information to the little that is known about access to essential medicines in rural China. Household surveys are not very common in this subject area, and I am pleased to see this one, which is well-performed. I would recommend the paper to be accepted as it stands.
VERSION 1 -AUTHOR RESPONSE
For Reviewer 1: Although this study followed a standardised method and applied it correctly, there are a number of issues that need to be addressed: Answer: We appreciate your comments, which will encourage us to do better job in the future research. Thank you very much for your useful suggestions and comments! Q1：Abstract -instead of stating than an "adaption" of the WHO/HAI methods was used, which seems to imply some deviation from the standard, it would be sufficient to state that "The WHO/HAI standardized methodology was use …" Answer: According to your requirement, We have changed this sentence into "The World Health Organization/Health Action International (WHO/HAI) standardized methodology was used to collect the availability and price data for 40 essential medicines for Children." (Page3, Line 8-10). Q2. Introduction -reference 9 is to a specific study conducted in Sudan. For the statement attributed to WHO, a WHO source would be preferable. Answer: We appreciate your comment, which will be valuable for our article. We agree and accept this comment. We have substituted the reference 9 for a WHO source. The statement comes from 'The World Medicines Situation 2011-Access to Essential Medicines as Part of the Right to Health'. The statement has been changed into "The World Health Organization (WHO) has estimated that at least one third of the world's population does not have regular access to essential medicines [9] and the challenges of poor access are also common for children [6, 8, 10 ]"(Page 6, Line 9-12). Reference . Introduction -reference 10 is a poor source for the claim that the majority of those who lack access to essential medicines are children, which may not be true. Instead, it would be better to state that the challenges of poor access are also common with children. Answer: Thank you so much for your useful suggestion. We agree and accept this comment. The statement has been revised in the Introduction. The reference 10 has been replaced and the expression has been revised. The reference 6,8 and 10 are the sources for the claim that the challenges of poor access are also common with children. These references refer to the surveys on the availability, prices and affordability of paediatric essential medicines which were conducted in China, Ethiopia and Guatemala.All of the results of the above studies demonstrated that the challenges of poor access are also common with children. Therefore, the statement has been changed into "The World Health Organization (WHO) has estimated that at least one third of the world's population does not have regular access to essential medicines [9]and the challenges of poor access are also common for children [6, 8, 10 ]"(Page 6 Line 9-12 Table 1 is superfluous and can be deleted. It would also be useful to state why only "cities" were chosen, and whether this urban-biased sample might misrepresent the situation for the whole population. This also needs to be covered in the Limitations. Answer: Thank you and we accept this comment. The six cities were chosen by the convenient sampling. At the same time, we also considered their geographical position and level of economic development. According to your suggestion, the Table 1 has been deleted. According to the standardized methodology developed by WHO/HAI, Nanjing, the capital city of Jiangsu Province, was chosen as the major urban center, and an additional five areas within 1 day's travel of Nanjing were selected. In each survey area, we first selected the main public tertiary hospital, which was a Children's Hospital or Women and Children Health Hospital. Usually, the main public tertiary hospital is located in the centre area of each survey city. However, an additional four public sector medicine outlets, two secondary hospitals and two primary healthcare facilities were chosen within 3 h travel of the main hospital. It means that some secondary hospitals and primary healthcare facilities are located in the rural areas. Especially for primary healthcare facilities, which included the township health centers that are located in the countrysides. In each survey city, we selected one county-level secondary hospital or township health center and one rural retail pharmacy outlet by using convenient sampling. Thererfore, one rural public medicine outlet in each of the six areas were included and one rural retail pharmacy outlet per survey area were sampled. Thus 12 rural facilities in all was surveyed, which account for 20% of the sampled public and private facilities. We have added the description in the section of Method. ( Page11, Line20, Page12, Line 1-4 ) However, on the other hand, 80% of samples were located in urban areas. Thus, the urban-biased sample might misrepresent the situation for the whole population. We have also added this viewpoint in the section of Limitation. (Page 26, Line 19-20) Q6. Method-were the other public health facilities all within the cities surveyed, and yet up to 3 hours' travel away? How were the 5 pharmacies selected (random or convenience), and if the former, how was the sampling frame constructed? How did "chain" retail pharmacies differ from other "retail pharmacies". The assumption here is that the sampling frame for the public sector facilities existed in government records and that the facility type was consistently defined and recorded. Answer: Thank you so much for your suggestions and comments. Convenience sampling was used in this study, which is a non-probability sampling technique where subjects are selected because of their convenient accessibility and proximity to the researcher. Q 6-1: Method-were the other public health facilities all within the cities surveyed, and yet up to 3 hours' travel away? A: Yes, in each survey area, once the main public tertiary hospital was confirmed, then all of the other public health facilities within the cities constructed the sampling frame. In other words, the additional four public sector medicine outlets, two secondary hospitals and two primary hospitals were chosen within 3 h travel of the main hospital by convenience sampling.(Page11, Line 4-6) Q 6-2: How were the 5 pharmacies selected (random or convenience), and if the former, how was the sampling frame constructed? A: According to the methodology developed by WHO/HAI, five pharmacies were closest to each public medicine outlet. Therefore, the retail pharmacies were also chosen by convenience sampling. (Page11, Line20,Page12, Line1) Q 6-3: How did "chain" retail pharmacies differ from other "retail pharmacies". A: In this study, retail pharmacy was defined as a single outlet which provides prescription drugs, among other products. A retail pharmacy is not directly affiliated with any chain of pharmacies and is not owned (or operated) by a publicly traded company. On the other hand, retail chain pharmacies are retail outlets that share a brand and central management, and usually have standardized business methods and practices. Compared to the retail pharmacy, retail chain pharmacies have multiple store locations and larger business scale. We have added some necessary descriptions in the section of Method. (Page11, Line 15-18 ) Q 6-4: The assumption here is that the sampling frame for the public sector facilities existed in government records and that the facility type was consistently defined and recorded. A: Yes, based on the government records, the sampling frame for the public sector facilities was designed and the facility type was consistently defined and recorded. We have added some necessary descriptions in the section of Method. (Page 11 Line 1-2) Q7. The greatest challenge lies with the selection of the 40 medicines surveyed. Given the emphasis on paediatrics, and the decision to use a 20kg, 5-year-old child as the norm, the lack of oral liquid dosage forms in the list is striking. Only two "suspensions"are included, and of these only 1 is on the NEM. If amoxicillin-clavulanic acid for injection is listed in the NEM, why is there no provision for stepdown care with an oral liquid dosage form? What is provided for in primary health care (ambulatory) facilities? Some of the other selections also look questionable, such as ranitidine (largely supplanted by the proton pump inhibitors, of which omeprazole was included), ibuprofen tablets (since the suspension as listed), aminophylline (deleted from the WHO Model EML a number of years ago, and especially as salbutamol inhaler was listed). Propylthiouracil is an unusual choice for a survey that is comparing retail pharmacy and hospital access, and which would be expected to concentrate on common ambulatory care conditions. However, at this stage, the list cannot be altered, so the concerns raised will need to be dealt with in the Limitations. Answer: Thank you so much for your comments. We decided to accept your valuable suggestions.Indeed, the lack of oral liquid dosage forms in the list is one of the major limitations in this study. Although some essential medicines have oral liquid dosage forms, unfortunately, they don't have IRPs, leading to failure to make international comparisons.That's why they were not selected into our study. The explanations and revisions are as follows. Q 7-1: The greatest challenge lies with the selection of the 40 medicines surveyed. Given the emphasis on paediatrics, and the decision to use a 20kg, 5-year-old child as the norm, the lack of oral liquid dosage forms in the list is striking. Only two "suspensions"are included, and of these only 1 is on the NEM. A: In this study, all of the survey medicines on core list were selected from WHO's EMLc. On the other hand, the survey medicines on supplementary list were not selected from EMLc. The survey medicines on supplementary list were selected based on local children's diseases needs, the 2012 NEML, the feedback from several pediatric experts and literature reviews. Meanwhile, we selected the dosage forms of these medicines as research objects based on 2012 NEML. Totally, among 40 medicines surveyed, 36 medicines are on the 2012 NEML. However, apart from calamine, miconazole nitrate, mupirocin, and salbutamol, only 2 of the remaining survey medicines on the NEML have oral liquid dosage form, such as suspension. Moreover, only suspensions of ibuprofen and paracetamol are included in the 2012 NEML. But we could not identify exact strength of paracetamol suspension on 2012 NEML. In particular, amoxicillin/clavulanic acid suspension is not included in the 2012 NEML. Therefore, only one "suspension" on the 2012 NEML was included.
We have added some descriptions in the section of Limitations.(Page 27 Line 8-11) Q 7-2: If amoxicillin-clavulanic acid for injection is listed in the NEM, why is there no provision for stepdown care with an oral liquid dosage form? What is provided for in primary health care (ambulatory) facilities? A: The dosage forms of amoxicillin-clavulanic acid only include tablet, dry suspension, granules and injection in the 2012 NEML, and oral liquid dosage form is unavailable. Also dry suspension and granules could be converted to liquid by diluting and brewing with water, and both of them don't have IRPs. Considering amoxicillin-clavulanic acid for suspension has an IRP and it is also on the WHO's EMLc (2017), we selected it as one of core medicines. In the Chinese primary health care (ambulatory) facilities, the doctors or pharmacists usually provide the dry suspensions, granules and injections of amoxicillin-clavulanic acid to the pediatric patients. We have added some descriptions in the section of Limitations.(Page 27 Line 8-11) Q 7-3：Some of the other selections also look questionable, such as ranitidine (largely supplanted by the proton pump inhibitors, of which omeprazole was included), ibuprofen tablets (since the suspension as listed), aminophylline (deleted from the WHO Model EML a number of years ago, and especially as salbutamol inhaler was listed). A:Yes. Firstly, we agree that survey medicines were selected repeatedly, such as ranitidine and omeprazole, aminophylline and salbutamol. Ranitidine is not only both on the EMLc and 2012 NEML, but also it is still in clinical use in China. Although aminophylline has been deleted from the WHO Model EML several years ago, it is still on 2012 NEML in China. Besides, clinically, it is still in use due to its relative low price in China, that is why it was selected into our supplementary list. According to the WHO/HAI survey methodology, the medicines on core list have been selected based on the following criteria: global/regional burden of disease/prevalence patterns, evidence-based, availability and importance.The survey methodology allows for the addition of supplementary medicines selected at the national level. The following selection criteria should also be considered Propylthiouracil is an unusual choice for a survey that is comparing retail pharmacy and hospital access, and which would be expected to concentrate on common ambulatory care conditions. A: We totally agree that propylthiouracil is an unusual choice for a survey that is comparing retail pharmacy and hospital access, which is one of major limitations in our study. On the other hand, the literature indicates that hyperthyroidism is one of the most common diseases for children with endocrine diseases, also as the diet structure changes, the incidence of hyperthyroidism increases year by year in China Q 7-5: However, at this stage, the list cannot be altered, so the concerns raised will need to be dealt with in the Limitations. A: These issues have been added in the section of Limitations: Fourth, therapeutic alternatives or alternate dosage forms, such as traditional Chinese medicines, were not assessed. Due to the limitation of suitable dosage forms on the NEML, only medicines having IRPs were selected as surveyed objects and compared with those in other countries, which gave rise to a lack of oral liquid dosage forms in the survey list. In addition, some survey medicines were selected repeatedly, such as ranitidine, omeprazole, aminophylline and salbutamol, which could have led to sample bias. On the other hand, some survey medicines, such as propylthiouracil, could not be expected to be used only for common ambulatory care conditions. (Page 27 Line 8-15). Q8. In Table 2 , the dosage form for salbutamol is stated as "dose" -is this the metered dose inhaler (200 dose)? Answer: We agree and accept this comment. Because Table 1 has been deleted, Table 2 now have  become Table 1 . So the mistake in Table 1 has been corrected, the dosage form should be 'inhaler'. (Page 36, Table 1 ). Q9. In Table 6 , it is striking that the costs were calculated using predominantly (except for the calamine lotion and salbutamol inhaler) on the costs of oral solid dosage forms, which in most cases would provide difficult to administer to a 5-year-old child.
Is it the case that appropriate oral liquid dosage forms are rarely available in China and that prescriptions are filled with oral solid dosage forms which will need to be divided or somehow manipulated? Is there no access to paracetamol in liquid form, for example? This would be one of the most commonly stocked paediatric medicines in most settings. This issue deserves comment in the Discussion and Limitations.
Answer: Thank you so much for your suggestions and comments. Q 9-1: In Table 6 , it is striking that the costs were calculated using predominantly (except for the calamine lotion and salbutamol inhaler) on the costs of oral solid dosage forms, which in most cases would provide difficult to administer to a 5-year-old child. A: In China, the list of essential medicines for children is still unavailable, and lack of access to paediatric essential medicines has caused increasing concern. Strengths and dosage forms suitable for children, such as oral solutions, are in short supply in the market [6] . Therefore, in this study, in order to reduce the usage of oral solid dosage forms in the calculation of treatment affordability, the condition, varicella, chickenpox, has been changed into acute otitis media that is also a common and prevalent disease for children, which ceftazidime in injection could be used to treat. Given that it was inappropriate for children to use oral solid dosage forms and ibuprofen in suspension was included in our survey, paracetamol in tablet has been replaced by ibuprofen in suspension for pain/inflammation. As a result, in Table 5 , only the treatment affordability of three paediatric common conditions is calculated by using the cost of oral solid dosage forms. (Page20,Line 9-11,Page 27, Line16-18 ,Page 42, Table 5 ) Q 9-2: Is it the case that appropriate oral liquid dosage forms are rarely available in China and that prescriptions are filled with oral solid dosage forms which will need to be divided or somehow manipulated? A：Yes, it is. Apart from calamine, miconazole nitrate, mupirocin, and salbutamol, the dosage forms of survey medicines mainly include oral solid dosage forms (e.g., tablets, capsules, granules and dry suspensions) and injections. However, few surveyed medicines have oral liquid dosage forms on the 2012 NEML. NEML lacks oral liquid dosage forms such as suspensions, which is a problem, especially for children. In routine clinical treatment, doctors have become used to reducing the doses of adult medicines and have to divide the tablets for adults into pieces to deal with paediatric diseases [6] . (Page20,Line 11-18) Q 9-3: Is there no access to paracetamol in liquid form, for example? This would be one of the most commonly stocked paediatric medicines in most settings. A: No, there is access to paracetamol in liquid form in China. For instance, the oral solution of paracetamol such as suspensions is included in the 2012 NEML. However, according to previous experts interviews and pre-investigation, we found that tablet and suspension drops are mainly dosage forms for paracetamol in Jiangsu Province, and other oral liquid form is not in common. Unfortunately, the suspension drops don't have an IRP. In addition, as same as amoxicillin-clavulanic acid, some oral solid dosage forms of paracetamol such as dry suspension and granules are included in the 2012 NEML. Also dry suspension and granules could be converted to liquid by diluting and brewing with water, and both of them don't have IRPs. Considering the reason given above,we selected paracetamol in tablet at last. We have added some descriptions in the section of Limitations as follows: Due to the limitation of suitable dosage forms on the NEML, only medicines having IRPs were selected as surveyed objects and compared with those in other countries, which gave rise to a lack of oral liquid dosage forms in the survey list. In order to comment these issues, we have added some descriptions in the section of Limitations as follows: Fifth, the treatment affordability of three common paediatric conditions was calculated by using the cost of tablets or capsules. However, it is difficult for 5-year-old children to take oral solid dosage forms, which may have caused bias in estimating the affordability of standard treatment regiments. ( Page27, Line15-18) On the other hand, we have added some comments in the section of Discussion as follows: In China, the list of essential medicines for children is still unavailable, and lack of access to paediatric essential medicines has caused increasing concern. Strengths and dosage forms suitable for children, such as oral solutions, are in short supply in the market [6] . In this study, the dosage forms of survey medicines mainly include oral solid dosage forms (e.g., tablets, capsules, granules and dry suspensions) and injections. However, few surveyed medicines have oral liquid dosage forms on the 2012 NEML. NEML lacks oral liquid dosage forms such as suspensions, which is a problem, especially for children. In routine clinical treatment, doctors have become used to reducing the doses of adult medicines and have to divide the tablets for adults into pieces to deal with paediatric diseases [6] . (Page20,Line 9-18) Q10. Discussion -the question of the viability of the current pricing and reimbursement model applied in the province needs more description and discussion. How is the "bidding and distribution" system in the public sector applied? How might that have affected access? How are retail pharmacists remunerated, apart from the percentage mark-up on the procurement price? Are there any additional dispensing or professional fees, and how are these regulated? Are wholesale or factory-gate prices regulated or do they vary considerably. Answer: Thank you for your useful comments. We agree and accept this comment. Q 10-1: How is the "bidding and distribution" system in the public sector applied? How might that have affected access? A: Since 2009, the centralized bidding procurement and distribution system for drugs was established at the provincial level to support the implementation of essential medicine policy [35] . The new centralized purchase policy has been implemented to shift purchasing power from medical institutions to the provincial committees [36] . Henceforth, all public facilities must be enrolled in the province-level centralized bidding and purchasing system, and 100% of medicines in public hospitals should be procured through this centralized tender. The pharmaceutical firms and suppliers were selected through a competitive bidding process by the provincial committee's jurisdiction, and then the products were distributed to all public facilities. Specifically, the pharmaceutical firms and suppliers who can win the tenders are limited. For a specific essential medicine with same strength and dosage form, only 3-5 firms can win the tender. Based on the present procurement policies in Jiangsu Province, only the firms that offer the lowest prices can win bids, which probably leads to shrinking revenues from drug sales and drives some firms to pull medicines from the market. Therefore, once the firms who win bids choose to abandon the tenders, some essential medicines are out of supply and stock [22] .(Page 21, Line 12-21, Page 22, Line1-6 )the procurement price, the lower the revenue from the markup. In fact, the retail pharmacies usually obtain their profit from the fixed wholesale and retail margins. Unlike in Western countries, not all of the retail pharmacists could get additional dispensing or professional fees, so their incomes depend mainly on wages and bonuses. To compensate the pharmacists for their dispensing services, the retail pharmacies tend to sell OBs because the patient prices of OBs are higher. (Page 22, Line 13-20) Q10-3: Are wholesale or factory-gate prices regulated or do they vary considerably. A: Since 2015, the Chinese government has liberated drug price regulation to the maximum extent possible. The wholesale or factory-gate prices of all medicines (except for narcotic drugs, psychoactive drugs, radioactive drugs, and toxic drugs for medical use) are not regulated by the government. However, due to the bidding system, the pharmaceutical companies which win bids offer the tender prices. As a result, there is relatively little difference between the prices of the same medicine with same strength and dosage form in the public sector. Conversely, due to a lack of regulations on prices, there were outrageous price differences in the private facilities. Furthermore, some OBs had high patient prices in retail pharmacies.
We have added the descriptions in the section of Discussion. ( Page 25, Line6-15) Q11. Finally, a carefully English language editing is needed. Answer: To improve the quality of the English, we had the manuscript edited by a professional editing service named American Journal Experts (AJE),which was recommended by BMJ Open. The editorial certificate provided by AJE can certifie that our manuscript was edited for proper English language, grammar,punctuation, spelling, and overall style by one or more of the highly qualified native English speaking editors.
For Reviewer 2: Questions: I have enjoyed reading the paper, which is well-written. The study is well-planned and executed, and adds interesting information to the little that is known about access to essential medicines in rural China. Household surveys are not very common in this subject area, and I am pleased to see this one, which is well-performed. I would recommend the paper to be accepted as it stands. Answer： We appreciate your comments, which will encourage us to do better job in the future research. Thank you very much for your useful suggestions and comments! VERSION 2 -REVIEW REVIEWER Andrew Lofts Gray University of KwaZulu-Natal, South Africa REVIEW RETURNED 30-Jul-2018
GENERAL COMMENTS
The authors have comprehensively addressed each of the concerns raised in the initial review and have made the necessary amendments to the manuscript. The methods are now clearly described, as are the limitations of the study. This is a very useful and timely contribution to the global literature and specifically in regard to the ongoing pharmaceutical policy reforms in China and the pathway towards universal health coverage.
